HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug

Oncogene

Volumn 30, Issue 43, 2011, Pages 4410-4427

  Wu, J ^a   Ru, N Y ^a   Zhang, Y ^a   Li, Y ^a   Wei, D ^a   Ren, Z ^b   Huang, X F ^a   Chen, Z N ^a   Bian, H ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD147; epithelial mesenchymal transition; hepatocarcinogenesis; hepatocellular carcinoma; PI3K Akt; TGF b

Indexed keywords

AQUAPORIN; CD147 ANTIGEN; GLYCOGEN SYNTHASE KINASE 3BETA; LUCIFERASE; NERVE CELL ADHESION MOLECULE; PROTEIN KINASE B; TRANSCRIPTION FACTOR SLUG; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, CD147; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

MUS MUSCULUS;

EID: 80055051887     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.149     Document Type: Article

References (40)

1. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. (2000). Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275: 36803-36810. (Pubitemid 32002090)
2. Battaglia S, Benzoubir N, Nobilet S, Charneau P, Samuel D, Zignego AL et al. (2009). Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS One 4: e4355.
3. Bedossa P, Peltier E, Terris B, Franco D, Poynard T. (1995). Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 21: 760-766.
4. Belton Jr RJ, Chen L, Mesquita FS, Nowak RA. (2008). Basigin-2 is a cell surface receptor for soluble basigin ligand. J Biol Chem 283: 17805-17814.
5. Chen ZN, Mi L, Xu J, Song F, Zhang Q, Zhang Z et al. (2006). Targeting radioimmunotherapy of hepatocellular carcinoma with iodine ((131)I) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol Biol Phys 65: 435-444.
6. Elsharkawy AM, Mann DA. (2007). Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46: 590-597. (Pubitemid 47344795)
7. Fransvea E, Angelotti U, Antonaci S, Giannelli G. (2008). Blocking transforming growth factor-beta upregulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology 47: 1557-1566. (Pubitemid 351702739)
8. Gabison EE, Mourah S, Steinfels E, Yan L, Hoang-Xuan T, Watsky MA et al. (2005). Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction. Am J Pathol 166: 209-219. (Pubitemid 40051673)
9. Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S. (2005). Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 129: 1375-1383. (Pubitemid 41597379)
10. Gou X, Ru Q, Zhang H, Chen Y, Li L, Yang H et al. (2009). HAb18G/ CD147 inhibits starvation-induced autophagy in human hepatoma cell SMMC7721 with an involvement of Beclin 1 downregulation. Cancer Sci 100: 837-843.
11. Huet E, Vallé e B, Szul D, Verrecchia F, Mourah S, Jester JV et al. (2008). Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling. FASEB J 22: 1144-1154. (Pubitemid 351519969)
12. Iacono KT, Brown AL, Greene MI, Saouaf SJ. (2007). CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol 83: 283-295. (Pubitemid 350087035)
13. Jiang JL, Zhou Q, Yu MK, Ho LS, Chen ZN, Chan HC. (2001). The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells. J Biol Chem 276: 46870-46877.
14. Labbé E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S et al. (2007). Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 67: 75-84. (Pubitemid 46142761)
15. Matsuzaki K. (2009). Modulation of TGF-beta signaling during progression of chronic liver diseases. Front Biosci 14: 2923-2934.
16. Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S et al. (2009). Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology 49: 1203-1217.
17. Li Y, Xu J, Chen L, Zhong WD, Zhang Z, Mi L et al. (2009). HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection. Histopathology 54: 677-687.
18. Liu F, Cui L, Zhang Y, Chen L, Wang Y, Fan Y et al. (2010). Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma. Breast Cancer Res Treat 124: 677-688.
19. Nitta T, Kim JS, Mohuczy D, Behrns KE. (2008). Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways. Hepatology 48: 909-919.
20. Peinado H, Olmeda D, Cano A. (2007). Snail1, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428. (Pubitemid 46809165)
21. Sidhu SS, Nawroth R, Retz M, Lemjabbar-Alaoui H, Dasari V, Basbaum C. (2010). EMMPRIN regulates the canonical Wnt/betacatenin signaling pathway, a potential role in accelerating lung tumorigenesis. Oncogene 29: 4145-4156.
22. Song BC, Chung YH, Kim JA, Choi WB, Suh DD, Pyo SI et al. (2002). Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma. Cancer 94: 175-180. (Pubitemid 34049056)
23. Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ et al. (2009). The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626-3636.
24. Tang J, Wu YM, Zhao P, Yang XM, Jiang JL, Chen ZN. (2008). Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways. Cell Mol Life Sci 65: 2933-2942.
25. Taura K, Miura K, Iwaisako K, Osterreicher CH, Kodama Y, Penz-Österreicher M et al. (2009). Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51: 1027-1036.
26. Thiery JP, Acloque H, Huang RY, (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
27. Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH, Moustakas A. (2008). HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem 283: 33437-33446.
28. Tsai JF, Jeng JE, Chuang LY, Yang ML, Ho MS, Chang WY et al. (1997). Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma. Br J Cancer 76: 244-250. (Pubitemid 27279666)
29. Valdé s F, Alvarez AM, Locascio A, Vega S, Herrera B, Ferná ndez M et al. (2002). The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor beta in fetal rat hepatocytes. Mol Cancer Res 1: 68-78.
30. Valdés F, Murillo MM, Valverde AM, Herrera B, Sánchez A, Benito M et al. (2004). Transforming growth factor-beta activates both proapoptotic and survival signals in fetal rat hepatocytes. Exp Cell Res 292: 209-218.
31. Vigneswaran N, Beckers S, Waigel S, Mensah J, Wu J, Mo J et al. (2006). Increased EMMPRIN (CD147) expression during oral carcinogenesis. Exp Mol Pathol 80: 147-159.
32. Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J et al. (2009). A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 11: 943-950.
33. Xu J, Lamouille S, Derynck R. (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172.
34. Xu J, Shen ZY, Chen XG, Zhang Q, Bian HJ, Zhu P et al. (2007a). A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation. Hepatology 45: 269-276. (Pubitemid 46374583)
35. Xu J, Xu HY, Zhang Q, Song F, Jiang JL, Yang XM et al. (2007b). HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Mol Cancer Res 5: 605-614. (Pubitemid 46985049)
36. Yan L, Han Y, Wang J, Liu J, Hong L, Fan D. (2007). Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes. Am J Hematol 82: 949-954. (Pubitemid 350004384)
37. Yang JD, Roberts LR. (2010). Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7: 448-458.
38. Yang YA, Zhang GM, Feigenbaum L, Zhang YE. (2006). Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2. Cancer Cell 9: 445-457. (Pubitemid 43832193)
39. Yi JY, Shin I, Arteaga CL. (2005). Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 280: 10870-10876. (Pubitemid 40395952)
40. Yoshino J, Monkawa T, Tsuji M, Inukai M, Itoh H, Hayashi M. (2007). Snail1 is involved in the renal epithelial-mesenchymal transition. Biochem Biophys Res Commun 362: 63-68. (Pubitemid 47296293)